| mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.9 |
| mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |